Home/Filings/4/0001019056-20-000439
4//SEC Filing

Maddux Randy Joe 4

Accession 0001019056-20-000439

CIK 0001671584other

Filed

Jul 28, 8:00 PM ET

Accepted

Jul 29, 9:37 PM ET

Size

20.4 KB

Accession

0001019056-20-000439

Insider Transaction Report

Form 4
Period: 2020-07-27
Maddux Randy Joe
Senior VP, Operations
Transactions
  • Award

    Stock Option (right to buy)

    2020-07-27+6,4236,423 total
    Exercise: $8.56Exp: 2030-07-26Common Stock (6,423 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-07-275,3570 total
    Exercise: $41.16Exp: 2026-08-03Common Stock (5,357 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-07-274,8140 total
    Exercise: $21.28Exp: 2029-02-28Common Stock (4,814 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-07-272,4070 total
    Exercise: $30.10Exp: 2027-06-01Common Stock (2,407 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-07-274,8140 total
    Exercise: $43.82Exp: 2028-03-09Common Stock (4,814 underlying)
  • Award

    Stock Option (right to buy)

    2020-07-27+2,1402,140 total
    Exercise: $8.56Exp: 2030-07-26Common Stock (2,140 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2020-07-272,4070 total
    Exercise: $27.44Exp: 2027-02-24Common Stock (2,407 underlying)
Footnotes (9)
  • [F1]Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020.
  • [F2]This stock option award vested over three years, and the final one-third vested on August 3, 2020.
  • [F3]In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4.
  • [F4]This stock option award vested over three years, and the final one-third vested on February 24, 2020.
  • [F5]This stock option award vested over three years, and the final one-third vested on June 1, 2020.
  • [F6]These options provide for vesting in three approximately equal annual installments beginning on March 9, 2018. Prior to July 27, 2020, all but 1,605 shares of the issuer's common stock underlying this stock option had vested.
  • [F7]These options provide for vesting in three approximately equal annual installments beginning on February 28. 2020. Prior to July 27, 2020, all but 3,210 shares of the issuer's common stock underlying this stock option had vested.
  • [F8]These options vest in full on the one year anniversary of the date of grant.
  • [F9]These options will vest in three approximately equal annual installments beginning on the one-year anniversary of the date of grant.

Documents

1 file

Issuer

Aptevo Therapeutics Inc.

CIK 0001671584

Entity typeother

Related Parties

1
  • filerCIK 0001683826

Filing Metadata

Form type
4
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 9:37 PM ET
Size
20.4 KB